ACTA1 and Hepatic fibrosis: Furthermore, PTK/ZK, a pan-VEGFR tyrosine kinase inhibitor, was shown to attenuate collagen deposition and α-smooth muscle actin (α-SMA) expression in CCl4-induced mouse liver fibrosis in both a ‘prevention’ and ‘treatment’ dosing scheme.